⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis
globenewswire.com
PFE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect
accessnewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
Институт Critical Path Institute запускает программу One to Millions, чтобы изменить будущее персонализированной медицины в глобальном масштабе USA - Pусский USA - English USA - English USA - Français USA - slovenčina USA - Polski USA - español USA -
prnewswire.com
BMY
MRK
PFE
GILD
REGN
AZN
NVS
BIIB
ALKS
CRIS
EDIT
NTLA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
Preliminary Results for the Year Ended 31 December 2025
globenewswire.com
BDRX
PFE
Colorectal Cancer Advocates Urge Congress to Fund New Research
globenewswire.com
EXAS
EXEL
GSK
GH
ISRG
MRK
NTRA
PFE
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players
globenewswire.com
PFE
JNJ
AMGN
ABBV
SNY
REGN
MRK
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
VALN
PFE
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
ABBV
SNY
BMY
AZN
NVS
AMGN